485-P: Alternate-Day Fasting and the 5:2 Diet Alleviate Distal Symmetric Polyneuropathy by Regulating Gut Microbiota and Metabolites

HUIJUAN YUAN
DOI: https://doi.org/10.2337/db24-485-p
IF: 7.7
2024-06-14
Diabetes
Abstract:Objective: Intermittent fasting (IF) regimens such as alternate-day fasting (ADF) and the 5:2 diet have shown promise in mitigating diabetes mellitus (DM). We aimed to investigate whether IF by altering the gut microbiota and related metabolites promotes distal symmetric polyneuropathy (DSPN), which is the most common neuropathy in patients with DM. Methods: Male db/db mice were subjected to ad libitum feeding, ADF, or the 5:2 diet to observe peripheral nerve function with or without an antibiotics cocktail treatment. Then we further verified the causality of the above symptoms by fecal microbiota transplantation. Results: Both ADF and the 5:2 diet improved DSPN, fortified gut barrier function and reduced inflammatory factor levels while causing changes in microbiota. Lactobacillus, etc were enriched in ADF diet-treated mice, Mucispirillum, etc increased in 5:2 diet-treated mice. Furthermore, ADF increased levels of metabolites such as gamma-tocopherol while the 5:2 diet increased levels of n-acetylhistamine and asparagine, and both diets decreased levels of n-acetylputrescine and phenylacetic acid. However, depletion of gut microbiota via antibiotics negated the neuroprotective effects of ADF and the 5:2 diet. Pseudo germ-free mice that received fecal transplants from ADF or 5:2 diet-treated mice exhibited improved peripheral nerve function and reduced inflammatory factor levels. Similarly, the stools from ADF increased the abundances of gamma-tocopherol, while the 5:2 diet decreased N-acetylputrescine, both repaired gut barrier in colonic epithelium of pseudo germ-free mice. Conclusion: Gut microbiota plays a significant role in the onset and progression of DSPN. Both ADF and the 5:2 diet appear to ameliorate DSPN by regulating gut microbiota, altering gut metabolites, reducing inflammatory factor levels and restoring gut barrier function. Disclosure H. Yuan: None. Funding National Natural Science Foundation of China under Grant (81970705, 82270865)
endocrinology & metabolism
What problem does this paper attempt to address?